emerg
reemerg
infecti
diseas
strong
neg
impact
public
health
howev
mani
pathogen
must
handl
biosafeti
level
contain
laboratori
research
develop
antivir
vaccin
diseas
often
imped
altern
approach
address
issu
vigor
pursu
particularli
use
pseudovirus
place
wildtyp
virus
pseudovirus
depriv
certain
gene
sequenc
virul
viru
handl
biosafeti
level
laboratori
importantli
envelop
viral
particl
may
similar
conform
structur
wildtyp
virus
make
feasibl
conduct
mechanist
investig
viral
entri
evalu
potenti
neutral
antibodi
howev
varieti
challeng
issu
remain
includ
product
suffici
pseudoviru
yield
inabl
produc
appropri
pseudotyp
certain
virus
review
discuss
current
progress
develop
pseudovirus
dissect
factor
contribut
low
viral
yield
pseudoviru
recombin
viral
particl
corebackbon
envelop
protein
deriv
differ
virus
moreov
gene
insid
pseudoviru
usual
alter
modifi
unabl
produc
surfac
protein
addit
plasmid
stabl
cell
line
express
surfac
protein
need
make
pseudoviru
pseudovirus
capabl
infect
suscept
cell
replic
round
infect
host
cell
compar
wildtyp
wt
virus
pseudovirus
safe
handl
biosafeti
level
bsl
laboratori
usual
easier
manipul
experiment
nevertheless
conform
structur
pseudovir
surfac
protein
bear
high
similar
nativ
viral
protein
surfac
protein
effect
mediat
viral
entri
host
cell
therefor
pseudovirus
wide
use
studi
cellular
tropism
receptor
recognit
viru
inhibit
well
develop
evalu
antibodi
vaccin
addit
data
vitro
pseudovirusbas
antivir
assay
vivo
biodistribut
analys
found
correl
well
result
gener
use
live
wt
virus
pseudovirus
usual
engin
carri
report
gene
much
easier
perform
quantit
analys
virus
wt
virus
number
pseudovirusinfect
cell
shown
directli
proport
report
gene
express
report
gene
usual
encod
either
enzym
fluoresc
protein
option
particular
strength
weak
specif
chemiluminesc
assay
usual
lower
background
sensit
data
acquisit
analys
assay
timeconsum
expens
contrast
assay
use
floresc
protein
green
fluoresc
protein
cheaper
easier
oper
vitro
vivo
system
howev
less
sensit
may
higher
background
review
provid
updat
develop
applic
pseudovir
system
discuss
challeng
technic
issu
packag
system
wide
use
pseudoviru
packag
system
make
packag
system
hiv
gene
select
clone
dna
vector
specif
plasmid
use
vector
strategi
aim
minim
viral
gene
recombin
therebi
reduc
possibl
revers
wt
viru
tabl
list
current
use
system
origin
system
compris
envelop
plasmid
backbon
plasmid
ie
env
gene
sequenc
destroy
howev
system
ideal
viral
yield
usual
low
improv
made
addit
sequenc
better
report
gene
express
specif
research
group
insert
report
gene
firefli
luciferas
fluc
env
nef
produc
addit
also
gener
carri
function
nef
cmv
promot
drive
report
gene
use
optim
backbon
envelop
protein
express
plasmid
group
succeed
produc
sever
hiv
pseudovirus
carri
envelop
protein
ebov
marv
lasv
middl
east
respiratori
syndromecoronaviru
rabi
viru
rv
chikungunya
viru
nipah
viru
niv
yield
pseudovirus
construct
optim
system
improv
compar
pseudovirus
construct
hiv
system
usual
compris
packag
plasmid
transfer
plasmid
contain
report
gene
envelopeexpress
plasmid
specif
system
made
split
backbon
separ
pack
transfer
plasmid
packag
plasmid
express
gag
pol
protein
transfer
plasmid
contain
cisregulatori
element
need
hiv
revers
transcript
integr
packag
well
multipl
clone
site
report
gene
control
heterogen
promot
envelopeexpress
plasmid
made
vector
carri
envelop
gene
driven
cmv
promot
hiv
system
base
system
rev
protein
express
addit
separ
plasmid
specif
system
compris
packag
plasmid
express
gag
pol
protein
second
packag
plasmid
encod
rev
plasmid
produc
wt
envelop
protein
transfer
plasmid
cisregulatori
element
hivbas
system
report
differ
group
yet
comparison
made
among
differ
system
safeti
effici
group
abl
drastic
improv
viral
yield
system
safeti
issu
hiv
pseudovir
system
observ
anim
simian
immunodefici
viru
packag
system
hiv
env
cellular
tropism
neutral
antibodi
assay
impact
env
amino
acid
mutat
glycosyl
neutral
epitop
drug
screen
valid
receptor
recognit
vsv
packag
system
versatil
tool
make
pseudotyp
virus
system
advantag
stringent
select
envelop
protein
result
viru
may
manipul
laboratori
earli
studi
jointli
employ
vsv
second
viru
coinfect
cell
result
pseudotyp
viru
carri
core
vsv
envelop
protein
deriv
viru
stillman
et
al
first
clone
vsv
genom
plasmid
make
stabl
vsv
subsequ
use
gener
pseudovirus
carri
heterogen
glycoprotein
variou
report
gene
success
insert
plasmid
facilit
easi
detect
exampl
vsvbase
pseudoviru
system
list
tabl
notabl
vsv
packag
system
use
make
pseudoviru
may
residu
vsv
viru
mix
pseudoviru
therebi
complic
neutral
assay
use
produc
falseposit
result
prefer
amount
vsv
minim
howev
excess
vsv
believ
interf
pseudovirusbas
assay
treatment
pseudoviru
prepar
vsv
neutral
antibodi
could
consid
use
futur
assay
mlv
packag
system
also
call
retrovir
system
commonli
use
make
pseudovirus
tabl
list
pseudovirus
packag
mlv
system
report
literatur
earli
work
witt
colleagu
show
use
vsv
infect
cell
mlv
packag
abl
harvest
pseudoviru
use
neutral
antibodi
assay
sinc
genom
mlv
split
part
one
encod
gagpol
contain
report
gene
gene
set
clone
plasmid
gener
highli
effici
mlv
packag
system
improv
stabil
system
investig
establish
sever
cell
line
confirm
stabl
transfect
express
murin
leukemia
viru
may
actual
better
choic
hiv
packag
system
case
exampl
studi
lasvmedi
entri
cell
cosset
et
al
compar
mlv
hiv
system
found
former
effici
latter
aforement
pseudoviru
packag
system
alway
success
gener
certain
type
pseudovirus
case
altern
revers
genet
report
exampl
hu
et
al
prepar
pseudotyp
dengu
viru
denv
type
use
hiv
system
titer
insuffici
high
howev
use
revers
genet
report
gene
high
yield
need
practic
applic
pseudovirus
sever
factor
critic
influenc
yieldtit
gener
subcellular
local
viral
packag
matura
success
use
mlv
packag
system
gener
pseudotyp
influenza
viru
cosset
et
al
reach
conclus
pseudotyp
lasv
prepar
moreov
experi
pseudotyp
lasv
packag
vsv
system
higher
titer
produc
use
hiv
system
furthermor
vsv
system
abl
incorpor
hantaviru
glycoprotein
fail
packag
hiv
nonetheless
group
develop
modif
hiv
packag
system
could
improv
pseudovir
yield
specif
backbon
plasmid
develop
lab
superior
packag
condit
also
drastic
influenc
pseudoviru
yield
hiv
packag
system
pseudoviru
titer
could
pseudovirus
wide
use
conduct
vitro
studi
interact
viru
host
cell
also
proven
use
vivo
studi
particularli
studi
mechan
viral
infect
well
biodistribut
lab
use
pseudotyp
rv
carri
report
gene
establish
vivo
imag
model
mice
mous
model
use
studi
viral
tissu
tropism
dynam
chang
time
also
establish
pseudotyp
ebov
mous
model
ebov
pseudovirus
mainli
detect
thymu
spleen
follow
viral
infect
reveal
pseudotyp
ebov
wt
ebov
tissu
tropism
group
also
use
pseudotyp
marv
small
anim
model
investig
viral
infect
applic
pseudovir
system
neutral
antibodi
antibodydepend
cellmedi
cytotox
assay
antibodi
neutral
assay
base
pseudovirus
wide
use
particularli
analys
virul
virus
would
otherwis
need
handl
laboratori
compar
tradit
assay
report
pseudovirusbas
assay
demonstr
good
correl
wt
virusbas
assay
pseudovirusbas
assay
usual
highthroughput
procedur
fewer
amount
serum
sampl
need
wilkinson
et
al
compar
platform
technolog
assay
antibodi
ebov
neutral
assay
use
wt
viru
found
best
assay
includ
method
base
wt
vsv
pseudotyp
neutral
elisa
lentivir
platform
problemat
